ロード中...
Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels
BACKGROUND: Chronic kidney disease (CKD) is a risk factor for end-stage renal failure and cardiovascular disease, and a strategy to counteract CKD must be established. CKD caused by immunological abnormalities is treated by steroids, frequently resulting in steroid diabetes. Although insulin is the...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scientific Literature, Inc.
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3989946/ https://ncbi.nlm.nih.gov/pubmed/24717767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.889872 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|